Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;112(12):2167-2177.
doi: 10.1111/add.13886. Epub 2017 Jul 4.

Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state

Affiliations

Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state

Rosanna Smart et al. Addiction. 2017 Dec.

Abstract

Aims: To (1) assess trends and variation in the market share of product types and potency sold in a legal cannabis retail market and (2) estimate how potency and purchase quantity influence price variation for cannabis flower.

Design: Secondary analysis of publicly available data from Washington State's cannabis traceability system spanning 7 July 2014 to 30 September 2016. Descriptive statistics and linear regressions assessed variation and trends in cannabis product variety and potency. Hedonic regressions estimated how purchase quantity and potency influence cannabis flower price variation.

Setting: Washington State, USA.

Participants: (1) A total of 44 482 176 million cannabis purchases, including (2) 31 052 123 cannabis flower purchases after trimming price and quantity outliers.

Measurements: Primary outcome measures were (1) monthly expenditures on cannabis, total delta-9-tetrahydrocannabinol (THC) concentration and cannabidiol (CBD) concentration by product type and (2) excise tax-inclusive price per gram of cannabis flower. Key covariates for the hedonic price regressions included quantity purchased, THC and CBD.

Findings: Traditional cannabis flowers still account for the majority of spending (66.6%), but the market share of extracts for inhalation increased by 145.8% between October 2014 and September 2016, now comprising 21.2% of sales. The average THC-level for cannabis extracts is more than triple that for cannabis flowers (68.7% compared to 20.6%). For flower products, there is a statistically significant relationship between price per gram and both THC [coefficient = 0.012; 95% confidence interval (CI) = 0.011-0.013] and CBD (coefficient = 0.017; CI = 0.015-0.019). The estimated discount elasticity is -0.06 (CI = -0.07 to -0.05).

Conclusions: In the state of Washington, USA, the legal cannabis market is currently dominated by high-THC cannabis flower, and features growing expenditures on extracts. For cannabis flower, both THC and CBD are associated with higher per-gram prices, and there are small but significant quantity discounts.

Keywords: Cannabis; drug policy; hedonic models; legalization; potency; prices.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest declaration: None

Figures

Figure 1
Figure 1. Trends in Product Sales
Notes: “Cannabis-Infused Edibles” contains both solids and liquids. “Cannabis Mix” includes products that mix several types of cannabis together, such as flower cured in kief. The “Other” product category combines tinctures, capsules, suppositories, and cannabis-infused topicals.
Figure 2
Figure 2. Distribution of THC & CBD in flower and inhalation extract purchases
Notes: For Figure 2B, restricting to observations with CBD concentration less than or equal to 4% preserves 98.6% of all flower observations and 93.9% of all extract observations.
Figure 3
Figure 3. Market shares for cannabis flower products sold, by THC% Category
Notes: Market share is calculated as a percent of total cannabis flower expenditures (excise-tax-inclusive).
Figure 4
Figure 4. Trends in Median Price per Gram and Price Variation for Cannabis Flower
Notes: Dashed lines represent the 25th and 75th percentiles.
Figure 5
Figure 5. Variation in tax-inclusive price of cannabis flower, by usable weight category
Notes: Whiskers extend from 1st to 99th percentile. Boxes represent the interquartile range segmented by median price. Disagreements in observations across Figure 5a and 5b are due to a small number of observations reported to have 0 THC.

Comment in

References

    1. Mclellan AA, Ware MA, Boyd S, Chow G, Jesso M, Kendall P, et al. A Framework for the Legalization and Regulation of Cannabis in Canada: The Final Report of the Task Force on Cannabis Legalization and Regulation. Ottawa, ON: Health Canada; 2016.
    1. Buckley WF. The war on drugs is lost. Natl Rev. 1996:34–48.
    1. Smith N. High potency cannabis: the forgotten variable. Addiction. 2005;100:1558–1560. - PubMed
    1. Ramaekers JG, Kauert G, Van Ruitenbeek P, Theunissen EL, Schneider E, Moeller MR. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology. 2006;31:2296–2303. - PubMed
    1. Di Forti M, Marconi A, Carra E, Fraietta S, Trotta A, Bonomo M, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry. 2015;2:233–238. - PubMed